Northern Trust Corp Pa Vmed Inc. Transaction History

Northern Trust Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.22 - $0.5 $2,821 - $6,412	-12,824 Reduced 8.46%	138,783 $41,000
Q1 2023 May 15, 2023	BUY	$0.36 - $0.63 $6,406 - $11,212	17,797 Added 13.3%	151,607 $56,000
Q4 2022 Feb 13, 2023	SELL	$0.41 - $18.6 $205 - $9,300	-500 Reduced 0.37%	133,810 $64,000
Q3 2022 Nov 14, 2022	SELL	$0.57 - $34.65 $9,614 - $584,476	-16,868 Reduced 11.16%	134,310 $116,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.41 $414,879 - $688,211	-488,093 Reduced 76.35%	151,178 $141,000
Q1 2022 May 13, 2022	SELL	$1.16 - $2.5 $34,864 - $75,140	-30,056 Reduced 4.49%	639,271 $844,000
Q4 2021 Feb 08, 2022	SELL	$2.46 - $8.74 $8,983 - $31,918	-3,652 Reduced 0.54%	669,327 $1.65 Million
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $230,642 - $424,653	-45,224 Reduced 6.3%	672,979 $5.75 Million
Q2 2021 Aug 13, 2021	BUY	$3.95 - $6.88 $199,893 - $348,169	50,606 Added 7.58%	718,203 $4.6 Million
Q1 2021 May 12, 2021	BUY	$2.01 - $5.55 $537,001 - $1.48 Million	267,165 Added 66.72%	667,597 $2.96 Million
Q4 2020 Feb 11, 2021	SELL	$1.73 - $2.13 $29,193 - $35,943	-16,875 Reduced 4.04%	400,432 $849,000
Q3 2020 Nov 16, 2020	BUY	$1.76 - $2.17 $508,793 - $627,318	289,087 Added 225.46%	417,307 $743,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.65 $141,912 - $214,896	81,093 Added 172.07%	128,220 $271,000
Q1 2020 May 14, 2020	BUY	$1.15 - $3.29 $28,749 - $82,250	25,000 Added 112.98%	47,127 $93,000
Q3 2018 Nov 14, 2018	BUY	$1.11 - $1.64 $24,560 - $36,288	22,127 New	22,127 $29,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.